<Header>
<FileStats>
    <FileName>20241024_10-Q-A_edgar_data_1847345_0001493152-24-042407.txt</FileName>
    <GrossFileSize>377557</GrossFileSize>
    <NetFileSize>13316</NetFileSize>
    <NonText_DocumentType_Chars>84903</NonText_DocumentType_Chars>
    <HTML_Chars>99611</HTML_Chars>
    <XBRL_Chars>115276</XBRL_Chars>
    <XML_Chars>57423</XML_Chars>
    <N_Exhibits>6</N_Exhibits>
</FileStats>
<SEC-Header>
0001493152-24-042407.hdr.sgml : 20241024
<ACCEPTANCE-DATETIME>20241024171837
ACCESSION NUMBER:		0001493152-24-042407
CONFORMED SUBMISSION TYPE:	10-Q/A
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20240331
FILED AS OF DATE:		20241024
DATE AS OF CHANGE:		20241024

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PowerUp Acquisition Corp.
		CENTRAL INDEX KEY:			0001847345
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41293
		FILM NUMBER:		241393484

	BUSINESS ADDRESS:	
		STREET 1:		1200 BROADWAY, FLOOR 3
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10038
		BUSINESS PHONE:		561-704-8527

	MAIL ADDRESS:	
		STREET 1:		1200 BROADWAY, FLOOR 3
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10038

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PowsedrUp Acquisition Corp.
		DATE OF NAME CHANGE:	20210222

</SEC-Header>
</Header>

 0001493152-24-042407.txt : 20241024

10-Q/A
 1
 form10-qa.htm

UNITED
STATES 

 SECURITIES
AND EXCHANGE COMMISSION 

 Washington,
D.C. 20549 

FORM

(Amendment
No. 1) 

(Mark
One) 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 

For
the quarterly period ended 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 

For
the transition period from to 

Commission
File No. 

(Exact
 name of registrant as specified in its charter) 

N/A 
 
 (State
 or other jurisdiction of 
 incorporation
 or organization) 
 
 (I.R.S.
 Employer 
 Identification
 No.) 

, 
 
 (Address
 of Principal Executive Offices, including zip code) 

Tel:

(Registrant s
 telephone number, including area code) 

N/A 
 
 (Former
 name, former address and former fiscal year, if changed since last report) 

Securities
registered pursuant to Section 12(b) of the Act: 

Title
 of each class 
 
 Trading
 Symbol(s) 
 
 Name
 of each exchange on which registered 

Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days. No 

Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant
was required to submit such files). No 

Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company, or an emerging growth company. See the definitions of large accelerated filer, accelerated filer, 
 smaller reporting company, and emerging growth company in Rule 12b-2 of the Exchange Act. 

Large accelerated filer 
 
 Accelerated filer 

Smaller reporting company 

Emerging growth company 

If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act): No 

As
of May 31, 2024 there were Class A ordinary shares, par value 0.0001 per share, and Class B ordinary shares, 0.0001 par
value per share, issued and outstanding. 

Explanatory
Note 

POWERUP
ACQUISITION CORP. 

 FORM
10-Q/A FOR THE QUARTER ENDED MARCH 31, 2024 

 TABLE
OF CONTENTS 

Page 
 
 PART II OTHER INFORMATION 
 1 

Item
 6. 
 Exhibits 
 1 

SIGNATURES 
 2 

i 

 Table of Contents 

PART
II - OTHER INFORMATION 

ITEM
6. EXHIBITS 

The
following exhibits are filed as part of, or incorporated by reference into, this Amendment No. 1 to Quarterly Report on Form 10-Q/A. 

Exhibit
 No. 
 
 Description 
 
 10.1 
 
 Loan and Transfer Agreement, dated January 9, 2024, by and among PowerUp Acquisition Corp., SRIRAMA Associates, LLC, and Apogee Pharma Inc. (incorporated by reference from Exhibit 10.11 to the Form 10-K filed by PowerUp Acquisition Corp. on March 11, 2024). 
 
 10.2 
 
 Amendment No. 1 to Secured Convertible Promissory Note, dated January 18, 2024, by and between Visiox Pharmaceuticals, Inc. and SRIRAMA Associates, LLC (incorporated by reference from Exhibit 10.13 to the Form S-4 filed by PowerUp Acquisition Corp. on January 26, 2024). 
 
 10.3 
 
 Form of Subscription Agreement dated March 5, 2024, by and among PowerUp Acquisition Corp., SRIRAMA Associates, LLC, VKSS Capital, LLC, Visiox Pharmaceuticals, Inc., and Investor (incorporated by reference from Exhibit 10.12 to the Form 10-K filed by PowerUp Acquisition Corp. on March 11, 2024). 
 
 10.4 
 
 Form of Subscription Agreement dated May 9, 2024, by and among PowerUp Acquisition Corp., SRIRAMA Associates, LLC, VKSS Capital, LLC, and Investor (incorporated by reference from Exhibit 10.16 to Amendment No. 1 to the Form S-4 filed by PowerUp Acquisition Corp. on May 14, 2024). 
 
 10.5 
 
 Form of Non-Redemption Agreement (incorporated by reference from Exhibit 10.1 to the Form 8-K filed by PowerUp Acquisition Corp. on May 22, 2024). 
 
 31.1 
 
 Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. 
 
 31.2 
 
 Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. 
 
 32.1 
 
 Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (incorporated by reference from Exhibit 32.1 to the Form 10-Q filed by PowerUp Acquisition Corp. on June 5, 2024). 
 
 32.2 
 
 Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. (incorporated by reference from Exhibit 32.2 to the Form 10-Q filed by PowerUp Acquisition Corp. on June 5, 2024). 
 
 101.INS 
 
 Inline
 XBRL Instance Document 
 
 101.CAL 
 
 Inline
 XBRL Taxonomy Extension Calculation Linkbase Document 
 
 101.SCH 
 
 Inline
 XBRL Taxonomy Extension Schema Document 
 
 101.DEF 
 
 Inline
 XBRL Taxonomy Extension Definition Linkbase Document 
 
 101.LAB 
 
 Inline
 XBRL Taxonomy Extension Labels Linkbase Document 
 
 101.PRE 
 
 Inline
 XBRL Taxonomy Extension Presentation Linkbase Document 
 
 104 
 
 Cover
 Page Interactive Data File (formatted in Inline XBRL and included as Exhibit 101) 

Filed
herewith. 

1 

 Table of Contents 

SIGNATURES 

In
accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized. 

POWERUP
 ACQUISITION CORP. 

Date:
 October 24, 2024 
 By: 
 /s/
 Surendra Ajjarapu 

Name: 
 Surendra
 Ajjarapu 

Title: 
 Chief
 Executive Officer 

(Principal
 Executive Officer) 

Date:
 October 24, 2024 
 By: 
 /s/
 Howard Doss 

Name: 
 Howard
 Doss 

Title: 
 Chief
 Financial Officer 

(Principal
 Financial and Accounting Officer) 

2 

<EX-31.1>
 2
 ex31-1.htm

Exhibit
31.1 

CERTIFICATION
OF PRINCIPAL EXECUTIVE OFFICER 

 PURSUANT
TO RULE 13A-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934, 

 AS
ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 

I,
Surendra Ajjarapu, certify that: 

1.
I have reviewed this quarterly report on Form 10-Q, as amended, of PowerUp Acquisition Corp.; 

2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the
period covered by this report; 

3.
[Intentionally omitted]; 

4.
The registrant s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and 15(d)-15(e)) and internal control over financial reporting (as defined in Exchange Act
Rules 13a-15(f) and 15d-15(f)) for the registrant and have: 

(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others
within those entities, particularly during the period in which this report is being prepared; 

(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under
our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements
for external purposes in accordance with generally accepted accounting principles; 

(c)
Evaluated the effectiveness of the registrant s disclosure controls and procedures and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
and 

(d)
Disclosed in this report any change in the registrant s internal control over financial reporting that occurred during the registrant s
most recent fiscal quarter (the registrant s fourth fiscal quarter in the case of an annual report) that has materially affected,
or is reasonably likely to materially affect, the registrant s internal control over financial reporting; and 

5.
The registrant s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to the registrant s auditors and the audit committee of the registrant s board of directors (or persons performing
the equivalent functions): 

(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrant s ability to record, process, summarize and report financial information;
and 

(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant s
internal control over financial reporting. 

Date:
 October 24, 2024 

/s/
 Surendra Ajjarapu 

Surendra
 Ajjarapu 

Chief
 Executive Officer 
 (Principal
 Executive Officer) 

</EX-31.1>

<EX-31.2>
 3
 ex31-2.htm

Exhibit
31.2 

CERTIFICATION
OF PRINCIPAL FINANCIAL OFFICER 

 PURSUANT
TO RULE 13A-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934, 

 AS
ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 

I,
Howard Doss, certify that: 

1.
I have reviewed this quarterly report on Form 10-Q, as amended, of PowerUp Acquisition Corp.; 

2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the
period covered by this report; 

3.
[Intentionally omitted]; 

4.
The registrant s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act
Rules 13a-15(f) and 15d-15(f)) for the registrant and have: 

(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others
within those entities, particularly during the period in which this report is being prepared; 

(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under
our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements
for external purposes in accordance with generally accepted accounting principles; 

(c)
Evaluated the effectiveness of the registrant s disclosure controls and procedures and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
and 

(d)
Disclosed in this report any change in the registrant s internal control over financial reporting that occurred during the registrant s
most recent fiscal quarter (the registrant s fourth fiscal quarter in the case of an annual report) that has materially affected,
or is reasonably likely to materially affect, the registrant s internal control over financial reporting; and 

5.
The registrant s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to the registrant s auditors and the audit committee of the registrant s board of directors (or persons performing
the equivalent functions): 

(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrant s ability to record, process, summarize and report financial information;
and 

(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant s
internal control over financial reporting. 

Date:
 October 24, 2024 

/s/
 Howard Doss 

Howard
 Doss 

Chief
 Financial Officer 
 (Principal Financial Officer) 

</EX-31.2>

<EX-101.SCH>
 4
 pwup-20240331.xsd
 XBRL SCHEMA FILE

</EX-101.DEF>

<EX-101.LAB>
 6
 pwup-20240331_lab.xml
 XBRL LABEL FILE

</EX-101.LAB>

<EX-101.PRE>
 7
 pwup-20240331_pre.xml
 XBRL PRESENTATION FILE

</EX-101.PRE>

